STRYKER CORP

SYK · NYSE · SIC 3841: Surgical & Medical Instruments & Apparatus · Market Cap: $127.3B · 56,000 employees
171
SEC Filings
$339.15
Close 2026-04-10
9
Transcripts
56,000
Employees

Business Summary

Stryker Corporation is a global medical technology company offering innovative products in MedSurg, Neurotechnology, and Orthopaedics. Key products include surgical equipment, endoscopic systems, patient handling equipment, Mako robotic-arm assisted technology, joint replacement implants, neurovascular devices, and AI-assisted virtual care platforms. Products are sold in approximately 61 countries, serving doctors, hospitals, and healthcare facilities, impacting more than 150 million patients annually.

Latest Stock Quote

SYK 2026-04-10 $339.15 O:$342.89 H:$345.175 L:$337.03 Vol:1.7M VWAP:$340.1537
origin leaf: 3efb5e8b2b5ecaefe5ad9d3adfcf6eb5c3138b9f4fefe74643c7bee02dda0903

Next Earnings

Q2 FY2026 — expected 2026-07-23

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSYKdiscussed Artificial Intelligence
topic_mentionSYKdiscussed Regulation
topic_mentionSYKdiscussed Healthcare & Bio
topic_mentionSYKdiscussed Semiconductor
topic_mentionSYKdiscussed Supply Chain
topic_mentionSYKdiscussed Regulation
topic_mentionSYKdiscussed Sovereign & Government
topic_mentionSYKdiscussed Healthcare & Bio
metricSYK gross marginreported $14.3 percent
guidanceSYKguided guidance reiterates our previous guidance inclusive of dilution from the Inari acquisition while also offsetting a tariff impact of approximately $200 million
outlookSYKstated We expect our adjusted net earnings per diluted share (2) to be the range of $13
outlookSYKstated We believe these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and asse
topic_mentionSYKdiscussed Semiconductor
topic_mentionSYKdiscussed Supply Chain
topic_mentionSYKdiscussed Regulation
topic_mentionSYKdiscussed Sovereign & Government
topic_mentionSYKdiscussed Healthcare & Bio
metricSYK gross marginreported $18.7 percent
outlookSYKstated We believe these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and asse
topic_mentionSYKdiscussed Artificial Intelligence

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-112025-12-310000310764-26-000010EDGAR50K words
2025-02-122024-12-310000310764-25-000023EDGAR
2024-02-142023-12-310000310764-24-000024EDGAR
2023-02-102022-12-310000310764-23-000017EDGAR
2022-02-112021-12-310000310764-22-000028EDGAR
2021-02-112020-12-310000310764-21-000027EDGAR
2020-02-062019-12-310000310764-20-000014EDGAR
2019-02-072018-12-310000310764-19-000014EDGAR
2018-02-082017-12-310000310764-18-000031EDGAR
2017-02-092016-12-310000310764-17-000034EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-10-312025-09-300000310764-25-000129EDGAR19K words
2025-08-012025-06-300000310764-25-000107EDGAR
2025-05-022025-03-310000310764-25-000075EDGAR
2024-10-302024-09-300000310764-24-000115EDGAR
2024-07-312024-06-300000310764-24-000098EDGAR
2024-05-012024-03-310000310764-24-000064EDGAR
2023-11-032023-09-300000310764-23-000116EDGAR
2023-08-042023-06-300000310764-23-000106EDGAR
2023-05-022023-03-310000310764-23-000067EDGAR
2022-11-012022-09-300000310764-22-000105EDGAR
2022-07-272022-06-300000310764-22-000092EDGAR
2022-04-292022-03-310000310764-22-000062EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-230001193125-26-118634EDGAR2K words
2026-03-120001193125-26-104431EDGAR
2026-03-110001193125-26-102460EDGAR
2026-01-290000310764-26-000006EDGAR
2025-12-040001193125-25-308097EDGAR
2025-10-300000310764-25-000126EDGAR
2025-07-310000310764-25-000103EDGAR
2025-05-130000310764-25-000085EDGAR
2025-05-010000310764-25-000072EDGAR
2025-02-270001193125-25-039302EDGAR

171 total filings indexed. 139 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Earnings Transcripts

Call DateQuarterTitle
SYK Earnings Call Transcript
SYK Earnings Call Transcript
SYK Earnings Call Transcript
SYK Earnings Call Transcript
SYK Earnings Call Transcript
SYK Earnings Call Transcript
SYK Earnings Call Transcript
Q9 FY2025SYK Q9 FY2025 Earnings Call Transcript
SYK Earnings Call Transcript

Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.

Sector Peers

MMM — 3M CO ARAY — ACCURAY INC AEMD — AETHLON MEDICAL INC ALUR — ALLURION TECHNOLOGIES, INC. ANGO — ANGIODYNAMICS INC AORT — ARTIVION, INC. RCEL — AVITA Medical, Inc. ADGM — Adagio Medical Holdings, Inc.

Tags

orthopaedic-surgery neurotechnology-and-neurovascular surgical-equipment-and-navigation endoscopy patient-handling-and-emergency-medical-equipment intensive-care vascular-/-venous-thromboembolism spine-and-vertebral-augmentation trauma-and-extremities fda-510(k)-clearance medical-device-amendments-of-1976-to-the-federal-food,-drug-and-cosmetic-act

Company Identity

CIK0000310764
TickerSYK
ExchangeNYSE
SIC3841: Surgical & Medical Instruments & Apparatus
IncorporatedMI
Websitehttps://www.stryker.com
Listed1979-05-02

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fc024cb184bcab183308679c02563bac34a13f4a464c1cfa8c66e94561f50217
parent: d247dc9c816282424232d70c0a12048d7201af4553adb97d7e04b67e980976f9
content hash: 99816b69ab253be1562e6c1ad4a58707bfd185f967b9ee503995d851a5d12096
signed: 2026-04-13T04:47:42.341Z
sources: 32 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf